Cover image of the article: Comparing ultra rapid opiate detoxification with Methadone in recurrent of self-introduced addicted subjects

Image Credit:J Kermanshah Univ Med Sci

Comparing ultra rapid opiate detoxification with Methadone in recurrent of self-introduced addicted subjects

Authors

Hosein Farzam1, Khosro Farhadi1, Mansour Rezaei2,*, Alireza Tolouee3
1Dept. of Anestesiology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran
2Social Development Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
3School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran
*Corresponding Author: Corresponding author: Mansour Rezaei, Social Development Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran, Tel: +98 831 4274618 Email: mrezaei@kums.ac.ir

Journal of Kermanshah University of Medical Sciences:Vol. 14, issue 3; e79470
Published online:Dec 19, 2010
Article type:Research Article
Received:Nov 11, 2009
Accepted:Apr 20, 2010
How to Cite:Farzam H, Farhadi K, Rezaei M, Tolouee A. Comparing ultra rapid opiate detoxification with Methadone in recurrent of self-introduced addicted subjects. J Kermanshah Univ Med Sci. 2010;14(3):e79470. doi:

Abstract

Background: The common detoxification method is replacement of long effect opiate by short effect opiate and then reducing its amount gradually. More modern method is ultra rapid opiate detoxification (UROD) by opiate antagonists, which is performed by general anesthesia. The advantages of two methods have not been confirmed. This study aimed to compare effectiveness and withdrawal rate in both methods following up to a year.

Methods: 211 self-introduced patients who referred to Farabi hospital for withdrawal were enrolled in this cross sectional study during 2005-06. The patients underwent detoxification after psychiatry screening and addiction confirmation. They divided into two detoxified method groups (110 patients in UROD and 101 Methadone). Recurrent and suspected cases were confirmed or rejected by urinary test and more specific test respectively. Data was collected from available patients profiles and contacting with patients or their relatives and was analyzed using Chi-square & independent sample T-test.

Results: The results showed that addiction recurrent in UROD and Methadone groups was 35.7% and 56.4% respectively (P=0.002). The average age of recurrent subjects in UROD group was younger than successful population at that same group (27.95±5.2 vs. 31.4±7.1 years old, p=0.008).

Conclusion: This study suggested that chance of detoxification and successful withdrawal by UROD method is higher than Methadone method and younger patients are more likely to get the recurrence. It is recommended to compare these two methods in a prospective study by unifying both groups based on age and considering opiate use duration.

Highlights

Fulltext

The full text of this article is available on PDF

References

  • 1.
    The references of this article is available on PDF.

Copyright

© 2010, Journal of Kermanshah University of Medical Sciences. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.

Similar Articles

17
Sep
2014
Six-Month Follow-Up Study of Ultrarapid Opiate Detoxification With Naltrexone

Six-Month Follow-Up Study of Ultrarapid Opiate Detoxification With Naltrexone

Mohammad Forozeshfard,
Babak Hosseinzadeh Zoroufchi,
Mohammad Bagher Saberi Zafarghandi,
Razieh Bandari,
Behzad Foroutan

Forozeshfard M, Hosseinzadeh Zoroufchi B, Saberi Zafarghandi MB, Bandari R, Foroutan B. Six-Month Follow-Up Study of Ultrarapid Opiate Detoxification With Naltrexone. Int J High Risk Behav Addict. 2014;3(4):e20944. doi: https://doi.org/10.5812/ijhrba.20944

19
Mar
2007
Naltrexone Therapy and Relapse Rates of Opioid Dependent Individuals

Naltrexone Therapy and Relapse Rates of Opioid Dependent Individuals

F Tatary,
J Shakeri,
A Nasiri,
L Ghelichi,
Gh Abdoli

Tatary F, Shakeri J, Nasiri A, Ghelichi L, Abdoli G. Naltrexone Therapy and Relapse Rates of Opioid Dependent Individuals. J Kermanshah Univ Med Sci. 2007;10(4):e81827. doi:

16
Oct
2012
Assessment Role of Participation in Narcotic Anonymous in Opiate Dependents during Abstinence

Assessment Role of Participation in Narcotic Anonymous in Opiate Dependents during Abstinence

Hossien Zare,
Ahmad Alipoor,
mohammad reza mokhtaree,
mohammad nazer,
Mohammadreza Mokhtaree,
Ahmadreza Sayadi

Zare H, Alipoor A, mokhtaree MR, nazer M, Mokhtaree M, et al. Assessment Role of Participation in Narcotic Anonymous in Opiate Dependents during Abstinence. Zahedan J Res Med Sci. 2012;14(9):e93223. doi:

27
Feb
2014
Comparison of craving for opioid in opioid-dependent individuals and people under methadone maintenance treatment

Comparison of craving for opioid in opioid-dependent individuals and people under methadone maintenance treatment

Azita Chehri,
Fereshteh Mirzaei,
Habibolah Khazaei,
Omid Rezaei,
Hamed Ekhtiari,
Azarakhsh Mokri
,et al.

Chehri A, Mirzaei F, Khazaei H, Rezaei O, Ekhtiari H, et al. Comparison of craving for opioid in opioid-dependent individuals and people under methadone maintenance treatment. J Kermanshah Univ Med Sci. 2014;17(11):e74310. doi: https://doi.org/10.22110/jkums.v17i11.632

19
Aug
2017
Depression as a Risk Factor for Relapse After Inpatient Opioid Detoxification: 1-Year Follow-Up Study

Depression as a Risk Factor for Relapse After Inpatient Opioid Detoxification: 1-Year Follow-Up Study

Harsh Chalana,
Tanu Kundal,
Amandeep Singh Malhari

Chalana H, Kundal T, Singh Malhari A. Depression as a Risk Factor for Relapse After Inpatient Opioid Detoxification: 1-Year Follow-Up Study. Int J High Risk Behav Addict. 2017;6(3):e59543. doi: https://doi.org/10.5812/ijhrba.59543

More by these authors

Hosein FarzamPubMedScholar
Khosro FarhadiPubMedScholar
Mansour RezaeiPubMedScholar
Alireza ToloueePubMedScholar
Share
Cited by
Metrics